1921
Volume 27, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

Two cases of serum sickness from furazolidone (Furoxona®), prescribed for giardiasis in Latin America, are described. No previous case of serum sickness related to this drug has been reported in the United States. Tartrazine (yellow dye number 5), a component of furazolidone tablets (Furoxona) manufactured in Latin American countries but no longer included in the drug (Furoxone®) in the United States is suggested as a possible cause of serum sickness.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1978.27.762
1978-07-01
2017-11-24
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1978.27.762
Loading
  • Accepted : 11 Feb 1978

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error